Sort
40,608 grants matching “prostate cancer”
GRANZYME B PET AS A NOVEL MEANS TO ASSESS T-CELL ACTIVATION IN RESPONSE TO 177LU-PSMA-617 PRIMING IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
$685,497Regents Of The University Of California, San Francisco, The · · FY2022 · Department of the Army
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
$685,408Anna M Wu · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$685,245Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$685,245Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
The Clinical PET Imaging of Metastatic Breast Cancer with Site-Specifically Labeled 89Zr-Trastuzumab
$685,217Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens
$685,130Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Maryland Prostate Cancer Case-Control Study
$685,102Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
The Molecular Profile of Prostate Tumors in African-American Men
$685,102Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
A Systems Biology Approach to the Development of Cancer Biomarkers
$685,047Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U01 · FY2012 · CA
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
$685,021William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2017 · CA
Novel Degraders of the Androgen Receptor (AR) and AR Splice Variants (AR-SVs)
$684,995Ramesh Narayanan · University Of Tennessee Health Sci Ctr · R01 · FY2021 · CA
Development/Clinical Validation Markers for Prostate Ca
$684,827Alan W Partin · Johns Hopkins University · U01 · FY2007 · CA
Circulating metabolites as novel risk biomarkers for gastric cancer: a large multi-center prospective investigation
$684,688Xiang Shu · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$684,659Udai S Kammula · Basic Sciences · Z01 · FY2007 · CA
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING
$684,591John Kurhanewicz · University Of California, San Francisco · R01 · FY2017 · CA
Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy
$684,576Kosj Yamoah · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2022 · CA
Biochemical and cellular analysis of regulatory T cells reactive to a natural self antigen
$684,530Erin June Adams · University Of Chicago · R01 · FY2017 · AI
Biochemical and cellular analysis of regulatory T cells reactive to a natural self antigen
$684,530Erin June Adams · University Of Chicago · R01 · FY2016 · AI
Growth Regulation Section
$684,396Ira Pastan · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes
$684,131Stephen Jay Freedland · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Multimodal MR-PET Machine Learning Approaches for Primary Prostate Cancer Characterization
$684,119Ciprian Catana · Massachusetts General Hospital · R01 · FY2018 · CA
Integration of circulating tumor cell and nuclear imaging biomarkers to assess LuPSMA response and resistance in advanced prostate cancer patients
$684,107Sheung Chee Thomas Ng · Massachusetts General Hospital · R01 · FY2025 · CA
Macrocycle inhibition of beta-catenin mediated transcription in prostate cancer
$684,075Susan K. Logan · New York University School Of Medicine · R01 · FY2025 · CA
High-Resolution Breast MRI at 3.0T
$684,033Brian Andrew Hargreaves · Stanford University · R01 · FY2022 · EB
The Clinical PET Imaging of Metastatic Breast Cancer with Site-Specifically Labeled 89Zr-Trastuzumab
$684,004Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA